Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 3:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–15 of 15 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 5% Minoxidil Clear all

Conditions: Female Androgenetic Alopecia
Interventions: 5% Minoxidil, 200mg Spironolactone, 5mg Finasteride, Placebo; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 60 Years and older · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Alopecia Areata, Alopecia Totalis, Alopecia Universalis
Interventions: Stem Cell Educator therapy; Combination Product
Lead sponsor: Throne Biotechnologies Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Paramus, New Jersey

Conditions: Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
Interventions: Post-Laser Minoxidil 2%, At-Home Minoxidil 5%, Laser, Post-laser 5mg minoxidil, Post-laser 10mg minoxidil, Post-laser 20mg minoxidil; Drug · Device
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years to 65 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Alopecia, Alopecia, Androgenetic, Baldness
Interventions: bimatoprost Formulation A, bimatoprost Formulation B, bimatoprost Formulation C, bimatoprost vehicle solution, minoxidil 5% solution; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 307 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Androgenetic Alopecia
Interventions: 5% Minoxidil Topical Foam, Vehicle Topical Foam; Drug
Lead sponsor: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 13
States / cities: Los Angeles, California • San Diego, California • Wichita, Kansas + 9 more

Conditions: Androgenetic Alopecia
Interventions: CB-03-01 solution, Minoxidil Solution 5%, Placebo solution; Drug
Lead sponsor: Intrepid Therapeutics, Inc.; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: San Diego, California • Fridley, Minnesota • Austin, Texas

Conditions: Androgenetic Alopecia
Interventions: 5% minoxidil topical foam; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years to 49 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Tucson, Arizona • Nashville, Tennessee

Conditions: Androgenetic Alopecia
Interventions: minoxidil; Drug
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 15 Years to 49 Years · Male only
Enrollment: 352 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2004
U.S. locations: 15
States / cities: La Jolla, California • San Francisco, California • Vallejo, California + 12 more

Conditions: Alopecia
Interventions: 5% Minoxidil, 2% Minoxidil; Drug
Lead sponsor: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 8
States / cities: Hot Springs, Arkansas • Minneapolis, Minnesota • Albuquerque, New Mexico + 4 more

Conditions: Alopecia
Interventions: Platelet Rich Plasma, Minoxidil Foam; Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Treatment Induced Hypertension
Interventions: Minoxidil, Hydralazine; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Male Pattern of Hair Loss, Androgenic Alopecia
Interventions: Treatment: Minoxidil 5% / Botanical Hair Solution for Men; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Alopecia, Female Pattern Hair Loss
Interventions: 5% minoxidil topical foam; Drug
Lead sponsor: Applied Biology, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Tucson, Arizona • Nashville, Tennessee

Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)
Interventions: Topical steroid class I-II, Triamcinolone Acetonide, Doxycyline, Minoxidil; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Permanent Chemotherapy-induced Alopecia
Interventions: oral minoxidil; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

Clinical Trial in Females for Female Pattern Hair Loss

A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia

Minoxidil Response Testing in Males With Androgenetic Alopecia

A Study to Evaluate the Effectiveness and Safety of 5 Percent Minoxidil Foam in the Treatment of Male Pattern Hair Loss

Clinical Trial in Females With Female Pattern Hair Loss

Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia

Minoxidil Response Testing in Females With Female Pattern Hair Loss

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia